cbdMD, Inc. (YCBD) stock
YCBDNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/3081% below fair value
$0.36+0.00 (+0.28%)
Close on Nov 17, 2026Market cap $4.08MP/E –Yield –
cbdMD ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
cbdMD's ebitda for the twelve months ending Sep 30, 2021 was -$18.60M. For fiscal 2021 it was -$18.60M. The highest annual figure on record is -$1.29M in fiscal 2017.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Sep 30, 2021 | -$18.60M | – |
| FY2020 | Sep 30, 2020 | -$16.86M | – |
| FY2019 | Sep 30, 2019 | -$14.51M | – |
| FY2018 | Sep 30, 2018 | -$1.57M | – |
| FY2017 | Sep 30, 2017 | -$1.29M | – |
| FY2016 | Sep 30, 2016 | -$3.84M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$32.96M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$6.72M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -$6.43M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$3.93M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -$1.53M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$4.31M | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$1.13M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$5.43M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$6.00M | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | -$5.19M | – |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -$6.37M | -1036.0% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | -$1.92M | -214.6% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -$1.03M | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -$2.69M | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $680.10K | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $1.68M | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -$1.24M | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$246.69K | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$164.03K | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$192.87K | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$686.31K | – |
See a number that looks wrong?